Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC]

Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] was reported 602 times

Drugs of the Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 MAGNETIC RESONANCE IMAGING HEPATOBILIARY ABNORMAL 1 0.1250
1 HEPATOBILIARY NEOPLASM 1 0.1000
2 UVEAL MELANOMA 5 0.0893
3 ANTERIOR SEGMENT NEOVASCULARISATION 1 0.0833
4 EXERTIONAL RHABDOMYOLYSIS 3 0.0811
5 METASTATIC OCULAR MELANOMA 2 0.0800
6 T-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0500
7 DELAYED ISCHAEMIC NEUROLOGICAL DEFICIT 1 0.0476
8 RESPIRATORY TRACT NEOPLASM 1 0.0417
9 CHOROIDAL DYSTROPHY 1 0.0208
10 ACHROMOTRICHIA ACQUIRED 1 0.0204
11 NEOPLASM SWELLING 1 0.0185
12 EYELASH DISCOLOURATION 4 0.0183
13 CHOROID MELANOMA 2 0.0177
14 URINARY TRACT NEOPLASM 1 0.0161
15 GENITOURINARY TRACT NEOPLASM 1 0.0120
16 GLUCOCORTICOID DEFICIENCY 4 0.0095
17 SOFT TISSUE NEOPLASM 1 0.0076
18 RETROPERITONEAL MASS 1 0.0072
19 CYTOKINE RELEASE SYNDROME 118 0.0059
20 INTRACARDIAC MASS 1 0.0056
21 METASTASES TO NERVOUS SYSTEM 1 0.0054
22 HAEMOFILTRATION 1 0.0053
23 MALIGNANT NEOPLASM OLIGOPROGRESSION 1 0.0050
24 EYE EXCISION 1 0.0049
25 TREATMENT DELAYED 8 0.0046
26 METASTASES TO EYE 1 0.0046
27 URTICARIA PAPULAR 1 0.0039
28 LEUKAEMIC INFILTRATION EXTRAMEDULLARY 1 0.0039
29 THUNDERCLAP HEADACHE 1 0.0038
30 NEOVASCULARISATION 1 0.0038
31 RETINAL DEPIGMENTATION 1 0.0033
32 THERAPEUTIC EMBOLISATION 1 0.0032
33 OESOPHAGEAL FISTULA 1 0.0031
34 HYPERCREATINAEMIA 1 0.0030
35 PROTHROMBIN LEVEL INCREASED 1 0.0029
36 TUMOUR FLARE 2 0.0029
37 METASTASES TO SKIN 3 0.0029
38 SKIN HYPOPIGMENTATION 5 0.0028
39 WEANING FAILURE 1 0.0027
40 SUBRETINAL FLUID 3 0.0027
41 SCAN ABNORMAL 1 0.0027
42 CREATINE KINASE INCREASED 2 0.0026
43 ASYMPTOMATIC COVID-19 1 0.0025
44 TUMOUR PAIN 3 0.0023
45 METASTASES TO PANCREAS 1 0.0023
46 MYELOID LEUKAEMIA 1 0.0020
47 ORBITAL OEDEMA 1 0.0020
48 IMMUNE-MEDIATED ADVERSE REACTION 3 0.0020
49 HYPHAEMA 1 0.0019
50 IRIS DISORDER 1 0.0019
51 EPHELIDES 1 0.0019
52 HEPATIC LESION 8 0.0018
53 HEPATORENAL FAILURE 1 0.0017
54 RETINAL DEGENERATION 2 0.0015
55 CENTRAL SEROUS CHORIORETINOPATHY 1 0.0015
56 CYTOKINE STORM 1 0.0015
57 INTENSIVE CARE 2 0.0014
58 ORTHOSTATIC INTOLERANCE 1 0.0014
59 GASTROINTESTINAL SURGERY 1 0.0013
60 PELVIC MASS 1 0.0012
61 OXYGEN THERAPY 2 0.0012
62 VITREOUS OPACITIES 1 0.0012
63 GASTROINTESTINAL NEOPLASM 1 0.0012
64 PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT 1 0.0011
65 HILAR LYMPHADENOPATHY 1 0.0011
66 HYPERLEUKOCYTOSIS 1 0.0011
67 METASTASIS 8 0.0011
68 MUSCLE SWELLING 1 0.0011
69 METASTASES TO ADRENALS 1 0.0011
70 BRAIN STEM HAEMORRHAGE 1 0.0011
71 SKIN OEDEMA 1 0.0010
72 LYMPHOCYTIC INFILTRATION 1 0.0010
73 BREAST NEOPLASM 1 0.0010
74 LYMPHANGIOSIS CARCINOMATOSA 1 0.0010
75 BLOOD LACTIC ACID INCREASED 5 0.0009
76 RADIATION INJURY 1 0.0009
77 AMAUROSIS FUGAX 1 0.0009
78 DISTRIBUTIVE SHOCK 2 0.0009
79 VITILIGO 2 0.0009
80 HEPATIC CANCER STAGE IV 3 0.0008
81 TACHYPNOEA 11 0.0008
82 XEROSIS 1 0.0008
83 SKIN DEPIGMENTATION 1 0.0007
84 OXYGEN SATURATION ABNORMAL 2 0.0007
85 TUMOUR HAEMORRHAGE 2 0.0007
86 INVESTIGATION ABNORMAL 1 0.0007
87 NONINFECTIVE GINGIVITIS 1 0.0007
88 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 4 0.0007
89 NEOPLASM SKIN 1 0.0006
90 POLYMYALGIA RHEUMATICA 2 0.0006
91 METASTASES TO LIVER 11 0.0006
92 HYPOXIA 22 0.0006
93 DISEASE PROGRESSION 73 0.0006
94 VEIN RUPTURE 1 0.0006
95 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
96 MALIGNANT NEOPLASM PROGRESSION 61 0.0006
97 HEPATORENAL SYNDROME 1 0.0006
98 HAIR COLOUR CHANGES 7 0.0006
99 RADIOTHERAPY 1 0.0005
100 RETINAL OEDEMA 1 0.0005
101 EARLY SATIETY 1 0.0005
102 CHILLS 59 0.0005
103 OSTEOLYSIS 1 0.0005
104 PIGMENTATION DISORDER 3 0.0005
105 ANAL PRURITUS 1 0.0005
106 LIVEDO RETICULARIS 1 0.0005
107 PULSELESS ELECTRICAL ACTIVITY 2 0.0005
108 HEPATIC PAIN 2 0.0005
109 LIMB MASS 1 0.0005
110 TUMOUR LYSIS SYNDROME 4 0.0005
111 BODY TEMPERATURE INCREASED 9 0.0004
112 METASTASES TO MENINGES 1 0.0004
113 METASTATIC MALIGNANT MELANOMA 1 0.0004
114 NEUROLOGICAL DECOMPENSATION 1 0.0004
115 NEOPLASM PROGRESSION 15 0.0004
116 URINARY TRACT OBSTRUCTION 1 0.0004
117 RASH VESICULAR 2 0.0004
118 BLOOD PRESSURE SYSTOLIC ABNORMAL 1 0.0004
119 GASTROINTESTINAL TUBE INSERTION 1 0.0004
120 METASTASES TO PERITONEUM 1 0.0004
121 METASTASES TO CENTRAL NERVOUS SYSTEM 5 0.0004
122 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
123 EXFOLIATIVE RASH 1 0.0004
124 ABDOMINAL MASS 1 0.0004
125 BRADYPNOEA 1 0.0004
126 BLOOD PHOSPHORUS INCREASED 1 0.0004
127 TYPE IV HYPERSENSITIVITY REACTION 1 0.0004
128 RHINALGIA 1 0.0004
129 VITREOUS HAEMORRHAGE 1 0.0004
130 RASH MORBILLIFORM 1 0.0004
131 NECROSIS 2 0.0004
132 ACUTE LYMPHOCYTIC LEUKAEMIA 1 0.0004
133 SKIN HYPERPIGMENTATION 3 0.0003
134 HYPOTENSION 70 0.0003
135 MYOSITIS 3 0.0003
136 PLATELET COUNT ABNORMAL 2 0.0003
137 DYSAESTHESIA 1 0.0003
138 ERYTHEMA MULTIFORME 3 0.0003
139 PYREXIA 107 0.0003
140 PRODUCT PREPARATION ISSUE 2 0.0003
141 METASTASES TO BONE 5 0.0003
142 NEAR DEATH EXPERIENCE 1 0.0003
143 BLOOD PRESSURE ABNORMAL 6 0.0003
144 SKIN MASS 2 0.0003
145 METASTASES TO SPINE 1 0.0003
146 SUDDEN CARDIAC DEATH 1 0.0003
147 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
148 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
149 FULL BLOOD COUNT ABNORMAL 3 0.0003
150 FIBRIN D DIMER INCREASED 1 0.0003
151 CONJUNCTIVAL HYPERAEMIA 1 0.0003
152 SKIN WEEPING 1 0.0003
153 HYPOPHOSPHATAEMIA 2 0.0003
154 ARTHROPOD BITE 2 0.0003
155 RASH MACULO-PAPULAR 6 0.0003
156 OXYGEN SATURATION DECREASED 15 0.0003
157 PROTEIN TOTAL DECREASED 1 0.0003
158 PEMPHIGOID 2 0.0003
159 HYPERTHERMIA 2 0.0003
160 METASTASES TO LUNG 3 0.0003
161 HYPOALBUMINAEMIA 2 0.0003
162 RHINOVIRUS INFECTION 1 0.0003
163 ACUTE MYELOID LEUKAEMIA 4 0.0003
164 HYPERURICAEMIA 1 0.0002
165 ANAPHYLACTOID REACTION 1 0.0002
166 HYPERPYREXIA 1 0.0002
167 MUSCLE FATIGUE 1 0.0002
168 POOR PERIPHERAL CIRCULATION 1 0.0002
169 HEPATITIS 6 0.0002
170 PRODUCT DISPENSING ISSUE 1 0.0002
171 CHAPPED LIPS 1 0.0002
172 IMMOBILE 1 0.0002
173 TACHYCARDIA 20 0.0002
174 URINARY TRACT DISORDER 1 0.0002
175 SUSPECTED OFF LABEL USE 1 0.0002
176 RETINAL DETACHMENT 2 0.0002
177 ISCHAEMIA 1 0.0002
178 RENAL FUNCTION TEST ABNORMAL 1 0.0002
179 GASTRITIS EROSIVE 1 0.0002
180 HEPATIC ENCEPHALOPATHY 2 0.0002
181 PERFORMANCE STATUS DECREASED 1 0.0002
182 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
183 BLOOD PRESSURE DECREASED 14 0.0002
184 ATELECTASIS 2 0.0002
185 HORMONE LEVEL ABNORMAL 1 0.0002
186 HEPATOMEGALY 2 0.0002
187 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
188 INFLAMMATORY MARKER INCREASED 1 0.0002
189 HEPATIC ENZYME ABNORMAL 1 0.0002
190 VULVOVAGINAL PRURITUS 1 0.0002
191 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
192 BRAIN FOG 3 0.0002
193 PRODUCT DOSE OMISSION ISSUE 56 0.0002
194 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
195 JAUNDICE 5 0.0002
196 LACTIC ACIDOSIS 6 0.0002
197 BLOOD BILIRUBIN INCREASED 5 0.0002
198 NONSPECIFIC REACTION 1 0.0002
199 PHOTOSENSITIVITY REACTION 3 0.0002
200 OCULAR DISCOMFORT 2 0.0002
201 SKIN TOXICITY 1 0.0002
202 PERIORBITAL SWELLING 1 0.0002
203 MYOCARDITIS 2 0.0002
204 BLOOD URIC ACID INCREASED 1 0.0002
205 ELECTROLYTE IMBALANCE 2 0.0002
206 ENERGY INCREASED 1 0.0002
207 ADRENAL INSUFFICIENCY 2 0.0002
208 DERMATITIS ACNEIFORM 1 0.0002
209 VULVOVAGINAL BURNING SENSATION 1 0.0002
210 CHOLANGITIS 1 0.0002
211 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
212 INFUSION SITE EXTRAVASATION 1 0.0002
213 RASH 69 0.0002
214 INTRAOCULAR PRESSURE INCREASED 2 0.0002
215 ENTERITIS 1 0.0002
216 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
217 INCOHERENT 1 0.0002
218 ULCER HAEMORRHAGE 1 0.0001
219 PRODUCT PREPARATION ERROR 3 0.0001
220 ONYCHOCLASIS 1 0.0001
221 RESPIRATION ABNORMAL 1 0.0001
222 MENTAL STATUS CHANGES 4 0.0001
223 HYPERTRANSAMINASAEMIA 1 0.0001
224 RETCHING 3 0.0001
225 PRODUCT SUPPLY ISSUE 1 0.0001
226 LIVER FUNCTION TEST INCREASED 3 0.0001
227 C-REACTIVE PROTEIN INCREASED 5 0.0001
228 NEUROPATHY PERIPHERAL 13 0.0001
229 SENSITIVE SKIN 1 0.0001
230 TRANSAMINASES INCREASED 3 0.0001
231 HEPATIC ENZYME INCREASED 9 0.0001
232 HEPATOCELLULAR CARCINOMA 1 0.0001
233 TROPONIN INCREASED 1 0.0001
234 LIPASE INCREASED 1 0.0001
235 FOOD ALLERGY 1 0.0001
236 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
237 BLOOD ALBUMIN DECREASED 1 0.0001
238 GINGIVAL PAIN 1 0.0001
239 EYE PAIN 7 0.0001
240 SHOCK HAEMORRHAGIC 1 0.0001
241 DECUBITUS ULCER 1 0.0001
242 ACUTE CORONARY SYNDROME 1 0.0001
243 SECOND PRIMARY MALIGNANCY 1 0.0001
244 HEMIPLEGIA 1 0.0001
245 SENSATION OF FOREIGN BODY 1 0.0001
246 SKIN PLAQUE 1 0.0001
247 FACIAL PARALYSIS 1 0.0001
248 THERAPY CESSATION 6 0.0001
249 PRODUCT CONTAINER ISSUE 1 0.0001
250 ANURIA 1 0.0001
251 PRURITUS 44 0.0001
252 ALANINE AMINOTRANSFERASE INCREASED 7 0.0001
253 HEART RATE DECREASED 4 0.0001
254 ASPARTATE AMINOTRANSFERASE INCREASED 6 0.0001
255 FACIAL PAIN 1 0.0001
256 LEUKOCYTOSIS 2 0.0001
257 SWELLING FACE 7 0.0001
258 HEPATIC FUNCTION ABNORMAL 4 0.0001
259 LEUKAEMIA 1 0.0001
260 SPUTUM DISCOLOURED 1 0.0001
261 RECALLED PRODUCT ADMINISTERED 1 0.0001
262 RASH ERYTHEMATOUS 5 0.0001
263 ACUTE RESPIRATORY FAILURE 2 0.0001
264 PRESCRIBED OVERDOSE 2 0.0001
265 AUTOIMMUNE DISORDER 1 0.0001
266 ASCITES 3 0.0001
267 HOSPICE CARE 1 0.0001
268 HEPATIC FAILURE 3 0.0001
269 TOXIC SKIN ERUPTION 1 0.0001
270 INCONTINENCE 1 0.0001
271 RENAL PAIN 1 0.0001
272 METABOLIC ACIDOSIS 3 0.0001
273 RASH PRURITIC 5 0.0001
274 BACK INJURY 1 0.0001
275 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
276 URINARY RETENTION 3 0.0001
277 HYPERTENSIVE CRISIS 1 0.0001
278 HEPATOTOXICITY 2 0.0001
279 BLISTER 5 0.0001
280 BLOOD CALCIUM DECREASED 1 0.0001
281 EYE INFECTION 1 0.0001
282 MICTURITION URGENCY 1 0.0001
283 NEOPLASM 1 0.0001
284 SHOCK 2 0.0001
285 GENERAL PHYSICAL HEALTH DETERIORATION 10 0.0001
286 THERAPY INTERRUPTED 6 0.0001
287 MYOCLONUS 1 0.0001
288 HEPATIC CANCER 2 0.0001
289 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
290 HEART RATE INCREASED 8 0.0001
291 BRAIN OEDEMA 1 0.0001
292 MUSCLE ATROPHY 1 0.0001
293 HEPATIC CYTOLYSIS 1 0.0001
294 ANAPHYLACTIC SHOCK 2 0.0001
295 VOMITING 36 0.0001
296 GASTRITIS 2 0.0001
297 DISORIENTATION 3 0.0001
298 PANCREATITIS 4 0.0001
299 ADVERSE REACTION 1 0.0001
300 EYE HAEMORRHAGE 1 0.0001
301 PAIN OF SKIN 2 0.0001
302 CONFUSIONAL STATE 12 0.0001
303 PNEUMONITIS 2 0.0001
304 RESPIRATORY DISTRESS 2 0.0001
305 PROCEDURAL PAIN 2 0.0001
306 HYPOMAGNESAEMIA 1 0.0001
307 BLOOD TEST ABNORMAL 1 0.0001
308 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
309 SKIN REACTION 1 0.0001
310 BLINDNESS UNILATERAL 1 0.0001
311 LYMPHOPENIA 1 0.0001
312 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
313 ERYTHEMA 14 0.0001
314 ANGIOEDEMA 3 0.0001
315 PULMONARY MASS 1 0.0001
316 APHASIA 2 0.0001
317 SKIN DISCOLOURATION 3 0.0001
318 THYROID DISORDER 1 0.0001
319 LYMPHOMA 1 0.0001
320 EJECTION FRACTION DECREASED 1 0.0001
321 SWELLING 6 0.0001
322 BLOOD POTASSIUM INCREASED 1 0.0001
323 INFUSION RELATED REACTION 4 0.0001
324 COAGULOPATHY 1 0.0001
325 SKIN EXFOLIATION 5 0.0001
326 MUSCULOSKELETAL DISCOMFORT 1 0.0001
327 ORTHOSTATIC HYPOTENSION 1 0.0001
328 NEUROTOXICITY 1 0.0001
329 COLD SWEAT 1 0.0001
330 HYPERTENSION 12 0.0001
331 DRUG ERUPTION 1 0.0001
332 ADVERSE DRUG REACTION 5 0.0001
333 OSTEOMYELITIS 1 0.0001
334 RESTLESS LEGS SYNDROME 1 0.0001
335 HYPERHIDROSIS 7 0.0001
336 TREMOR 9 0.0001
337 DYSGEUSIA 4 0.0001
338 HEPATIC CIRRHOSIS 1 0.0001
339 PHOTOPHOBIA 1 0.0001
340 DYSARTHRIA 2 0.0001
341 HYPOCALCAEMIA 1 0.0001
342 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
343 ATRIAL FIBRILLATION 5 0.0001
344 BONE PAIN 3 0.0001
345 NAUSEA 40 0.0001
346 HAEMATOCRIT DECREASED 1 0.0001
347 SPINAL FRACTURE 1 0.0000
348 FULL BLOOD COUNT DECREASED 1 0.0000
349 THERAPEUTIC RESPONSE DECREASED 3 0.0000
350 FEEDING DISORDER 1 0.0000
351 PLEURAL EFFUSION 3 0.0000
352 CARDIAC ARREST 4 0.0000
353 ASTHENIA 18 0.0000
354 DERMATITIS 1 0.0000
355 PLATELET COUNT DECREASED 5 0.0000
356 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
357 BLOOD CREATININE INCREASED 3 0.0000
358 PERIPHERAL SWELLING 7 0.0000
359 SEPSIS 5 0.0000
360 PERICARDIAL EFFUSION 1 0.0000
361 RENAL DISORDER 2 0.0000
362 BLOOD PRESSURE FLUCTUATION 1 0.0000
363 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
364 HYPOGLYCAEMIA 2 0.0000
365 RESPIRATORY FAILURE 3 0.0000
366 ENCEPHALOPATHY 1 0.0000
367 COVID-19 7 0.0000
368 CARDIOVASCULAR DISORDER 1 0.0000
369 FLUSHING 4 0.0000
370 UNRESPONSIVE TO STIMULI 1 0.0000
371 DIPLOPIA 1 0.0000
372 MUCOSAL INFLAMMATION 1 0.0000
373 SPEECH DISORDER 2 0.0000
374 BRADYCARDIA 2 0.0000
375 DEHYDRATION 5 0.0000
376 DEATH 32 0.0000
377 OEDEMA 2 0.0000
378 MOOD ALTERED 1 0.0000
379 TREATMENT NONCOMPLIANCE 2 0.0000
380 SKIN LESION 1 0.0000
381 ANAPHYLACTIC REACTION 2 0.0000
382 DIVERTICULITIS 1 0.0000
383 FEELING COLD 1 0.0000
384 HYPONATRAEMIA 2 0.0000
385 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
386 RED BLOOD CELL COUNT DECREASED 1 0.0000
387 ACUTE MYOCARDIAL INFARCTION 1 0.0000
388 RENAL INJURY 1 0.0000
389 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
390 BLOOD POTASSIUM DECREASED 1 0.0000
391 LACRIMATION INCREASED 1 0.0000
392 ILL-DEFINED DISORDER 2 0.0000
393 OEDEMA PERIPHERAL 4 0.0000
394 EPILEPSY 1 0.0000
395 ACUTE KIDNEY INJURY 5 0.0000
396 EMOTIONAL DISORDER 1 0.0000
397 NERVOUS SYSTEM DISORDER 1 0.0000
398 SWOLLEN TONGUE 1 0.0000
399 HEAD INJURY 1 0.0000
400 PULMONARY EMBOLISM 3 0.0000
401 HYPOTHYROIDISM 1 0.0000
402 MOVEMENT DISORDER 1 0.0000
403 DRUG INTOLERANCE 3 0.0000
404 NIGHT SWEATS 1 0.0000
405 DIARRHOEA 20 0.0000
406 FATIGUE 24 0.0000
407 CHOLELITHIASIS 1 0.0000
408 BACK PAIN 7 0.0000
409 RENAL FAILURE 4 0.0000
410 ABDOMINAL PAIN 7 0.0000
411 SKIN DISORDER 1 0.0000
412 GAIT INABILITY 1 0.0000
413 EYE PRURITUS 1 0.0000
414 MYALGIA 5 0.0000
415 ILLNESS 3 0.0000
416 DELIRIUM 1 0.0000
417 RASH MACULAR 1 0.0000
418 BURNING SENSATION 2 0.0000
419 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
420 CRYING 1 0.0000
421 AGITATION 2 0.0000
422 EYE SWELLING 1 0.0000
423 THROMBOCYTOPENIA 3 0.0000
424 MUSCULAR WEAKNESS 3 0.0000
425 COLITIS 1 0.0000
426 BLOOD PRESSURE INCREASED 4 0.0000
427 GAIT DISTURBANCE 5 0.0000
428 HOSPITALISATION 4 0.0000
429 SEIZURE 3 0.0000
430 DECREASED APPETITE 6 0.0000
431 PALPITATIONS 3 0.0000
432 DYSPNOEA 14 0.0000
433 PAIN 15 0.0000
434 INFLUENZA LIKE ILLNESS 2 0.0000
435 HEADACHE 15 0.0000
436 CARDIO-RESPIRATORY ARREST 1 0.0000
437 PAIN IN EXTREMITY 7 0.0000
438 LOSS OF CONSCIOUSNESS 3 0.0000
439 RECTAL HAEMORRHAGE 1 0.0000
440 BALANCE DISORDER 2 0.0000
441 SEPTIC SHOCK 1 0.0000
442 PRODUCT STORAGE ERROR 2 0.0000
443 MALAISE 10 0.0000
444 LIVER DISORDER 1 0.0000
445 THERAPY NON-RESPONDER 1 0.0000
446 ADVERSE EVENT 2 0.0000
447 HYPOKALAEMIA 1 0.0000
448 OROPHARYNGEAL PAIN 2 0.0000
449 OCULAR HYPERAEMIA 1 0.0000
450 DYSPHAGIA 2 0.0000
451 COMA 1 0.0000
452 BLOOD GLUCOSE DECREASED 1 0.0000
453 CONTUSION 2 0.0000
454 OFF LABEL USE 18 0.0000
455 DYSPEPSIA 2 0.0000
456 DRY EYE 1 0.0000
457 SYNCOPE 2 0.0000
458 SOMNOLENCE 4 0.0000
459 SINUSITIS 2 0.0000
460 HAEMOGLOBIN DECREASED 2 0.0000
461 INFLAMMATION 1 0.0000
462 ABDOMINAL DISTENSION 2 0.0000
463 MUSCULOSKELETAL PAIN 1 0.0000
464 PARAESTHESIA 3 0.0000
465 DISTURBANCE IN ATTENTION 1 0.0000
466 URINARY TRACT INFECTION 3 0.0000
467 HERPES ZOSTER 1 0.0000
468 LETHARGY 1 0.0000
469 DYSPHONIA 1 0.0000
470 SURGERY 1 0.0000
471 WHEEZING 1 0.0000
472 CATARACT 1 0.0000
473 FEELING ABNORMAL 4 0.0000
474 STOMATITIS 1 0.0000
475 FEELING HOT 1 0.0000
476 DEEP VEIN THROMBOSIS 1 0.0000
477 FEBRILE NEUTROPENIA 1 0.0000
478 PRODUCT QUALITY ISSUE 2 0.0000
479 ABDOMINAL PAIN UPPER 3 0.0000
480 WEIGHT DECREASED 4 0.0000
481 SKIN BURNING SENSATION 1 0.0000
482 INFECTION 2 0.0000
483 UNDERDOSE 1 0.0000
484 HOT FLUSH 1 0.0000
485 UNEVALUABLE EVENT 1 0.0000
486 ARTHRITIS 1 0.0000
487 DRUG INTERACTION 2 0.0000
488 DRY MOUTH 1 0.0000
489 DIZZINESS 6 0.0000
490 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
491 RENAL IMPAIRMENT 1 0.0000
492 MUSCULOSKELETAL STIFFNESS 1 0.0000
493 GASTROINTESTINAL DISORDER 1 0.0000
494 NO ADVERSE EVENT 2 0.0000
495 COUGH 3 0.0000
496 CARDIAC DISORDER 1 0.0000
497 PRODUCT USE ISSUE 2 0.0000
498 ANAEMIA 2 0.0000
499 MIGRAINE 1 0.0000
500 ALOPECIA 2 0.0000
501 CHEST DISCOMFORT 1 0.0000
502 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
503 ARTHRALGIA 4 0.0000
504 HAEMORRHAGE 1 0.0000
505 PNEUMONIA 3 0.0000
506 CONSTIPATION 2 0.0000
507 INFLUENZA 1 0.0000
508 RHEUMATOID ARTHRITIS 1 0.0000
509 DEPRESSION 2 0.0000
510 JOINT SWELLING 1 0.0000
511 EMOTIONAL DISTRESS 1 0.0000
512 VISUAL IMPAIRMENT 1 0.0000
513 DRUG INEFFECTIVE 10 0.0000
514 DRY SKIN 1 0.0000
515 NEUTROPENIA 1 0.0000
516 VISION BLURRED 1 0.0000
517 ANXIETY 2 0.0000
518 HYPOAESTHESIA 1 0.0000
519 FALL 2 0.0000
520 URTICARIA 1 0.0000
521 CEREBROVASCULAR ACCIDENT 1 0.0000
522 MYOCARDIAL INFARCTION 1 0.0000
523 BLOOD GLUCOSE INCREASED 1 0.0000
524 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
525 INCORRECT DOSE ADMINISTERED 1 0.0000
526 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
527 INSOMNIA 1 0.0000
528 CONDITION AGGRAVATED 1 0.0000
529 INJECTION SITE PAIN 1 0.0000